벼룩 및 진드기 구제약 시장 : 기회, 성장 촉진요인, 산업 동향 분석과 예측(2024-2032년)

The Global Flea and Tick Control Medication Market was valued at USD 6.7 billion and is projected to witness a CAGR of 7.1% from 2024 to 2032. The market's expansion is propelled by the growing occurrence of flea and tick-borne diseases in pets, a rise in pet ownership, and greater awareness of preventive healthcare measures. A report from the American Pet Products Association (APPA) highlights that 67% of U.S. households, or 85 million families, own pets, a trend observed worldwide. This growing pet population and increased expenditure on pet healthcare propel the demand for flea and tick medications. Innovations in product formulations, such as new active ingredients and combination products, have also improved treatment efficacy and safety, leading to market growth.

The overall flea and tick control medication industry is classified based on the product type, medication type, animal type, purchase channel and region.

Based on product type, the flea and tick control medication market is categorized into chewables, sprays, and other product types. The chewables segment dominated the market with USD 3.2 billion in 2023. Chewable medications are favored for their convenience, palatability, and effectiveness. They eliminate the mess associated with topical solutions and minimize exposure risks to children and other pets. These medications provide systemic action, ensuring robust protection against fleas and ticks from within the pet's body. The substantial market share held by chewables underscores their rising popularity and user-friendly nature.

Based on medication type, the flea and tick control medication market is segmented into prescription and OTC. The OTC segment held the highest market share of 62.6% in 2023. OTC products dominate due to their accessibility and convenience. They are available at pet stores, pharmacies, and online platforms, allowing pet owners to tackle infestations without a veterinary prescription. OTC solutions are often more affordable and come in various options tailored to different pets and needs. Growing awareness of pet health and the ease of direct purchases solidify the OTC segment's leading position.

North America's flea and tick control medication market was valued at USD 2.4 billion in 2023. North America holds a dominant position due to high pet ownership rates, awareness of parasite-related health concerns, and a robust veterinary healthcare infrastructure. Significant investments in research and development have resulted in a diverse range of innovative and effective products. The presence of major pharmaceutical companies and a well-established distribution network further strengthens the region's market stance. Focus on pet health and wellness, alongside stringent regulations for product safety and efficacy, solidifies North America's leading position.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising awareness of pet health
    • 3.2.1.2 Increasing pet ownership
    • 3.2.1.3 Growing importance of preventive care
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of medication
    • 3.2.2.2 Adverse effects
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Future market trends
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Chewables
• 5.3 Sprays
• 5.4 Other product types

Chapter 6 Market Estimates and Forecast, By Medication Type, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Prescription
• 6.3 OTC

Chapter 7 Market Estimates and Forecast, By Animal Type, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Dogs
• 7.3 Cats
• 7.4 Other animal types

Chapter 8 Market Estimates and Forecast, By Purchase Channel, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Veterinarian
• 8.3 Drug and pharmacy stores
• 8.4 Pet specialty stores
• 8.5 Supermarket / hypermarket
• 8.6 Online
• 8.7 Other purchase channels

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Bayer AG
• 10.2 Boehringer Ingelheim International GmbH
• 10.3 Central Garden and Pet Company
• 10.4 Central Life Sciences
• 10.5 Ceva Sante Animale
• 10.6 Ecto Development LLC
• 10.7 Elanco Animal Health Incorporated
• 10.8 Hartz Mountain Corporation
• 10.9 Merck and Co., Inc.
• 10.10 Penn Veterinary Supply, Inc.
• 10.11 Promika LLC
• 10.12 PetIQ, LLC
• 10.13 Virbac S.A.
• 10.14 Zoetis Inc.